At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 173 enrolled
Drug / intervention
Exercisebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Physical Activity and Total Health Trial
In Brief
A Phase 3 clinical trial evaluating Exercise for Breast Cancer Prevention. Completed, enrolled 173 participants across 1 site.
Detailed Summary
The goals of the study are to examine the effect in postmenopausal women of a one-year moderate intensity exercise intervention, as compared with a sedentary pattern (low-level stretching program), on: serum estrogens, androgens, sex hormone binding globulin, insulin, triglycerides, glucose, aromatase, FSH, LH, as well as parameters of body fat mass.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer Prevention
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 1997
Primary CompletionDec 2003
Study CompletionDec 2004
First PostedApr 2008
TodayJul 2026
First PostedApr 29, 2008
Enrollment StartJan 1, 1997
Primary CompletionDec 1, 2003
Study CompletionDec 1, 2004
TodayJul 2, 2026
Enrollment to primary: 6.9 yearsPosted 18.2 years ago
Interventions
Exercisebehavioral
Moderate intensity exercise, 5 days per week, 45 min per session, 50-70% max HR, divided into a 3-month individualized and 9-month maintenance period.